Business Services
Pharmaceutical Business Services – News, analysis and company profiles
BioInnovation Institute & Science Prize for Innovation winners announced
April 13, 2023 Business Services
COPENHAGEN, Denmark, April 13, 2023 – BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, …
ANGLE plc (“the Company”) Pharma Services Contract with Crescendo Biologics
April 13, 2023 Business Services
ANGLE plc (AIM: AGL; OTCQX: ANPCY), a world-leading liquid biopsy company, is delighted to announce that it has signed a …
Transgene’s Board of Directors Proposes the Appointment of Carol Stuckley, MBA, as New Independent Director
April 13, 2023 Business Services
Strasbourg, France, April 12, 2023, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops …
ENHERTU® ▼ (TRASTUZUMAB DERUXTECAN) ACCEPTED FOR USE WITHIN NHS SCOTLAND EARLIER IN THE TREATMENT PATHWAY FOR HER2-POSITIVE METASTATIC BREAST CANCER
April 12, 2023 Business Services
Daiichi Sankyo UK Limited and AstraZeneca UK Limited welcome the news that the Scottish Medicines Consortium (SMC) has accepted Enhertu®▼ …
Almirall, the first to assess wellbeing in a dermatology clinical study
April 12, 2023 Business Services
BARCELONA, Spain. April 12, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced the …
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
April 11, 2023 Business Services
CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science …
Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD
April 11, 2023 Business Services
LONDON and RALEIGH, N.C., April 11, 2023 – Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage …
Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
April 11, 2023 Business Services
Leiden, The Netherlands, April 11, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the first commercial …
Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study
April 6, 2023 Business Services
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces the opening …
Innova Care Concepts expand their support to the medical negligence sector with the acquisition of Nurture Group Ltd.
April 5, 2023 Business Services
Press Release, Wednesday 5th April 2023, London… As part of a long-term strategy to increase its home adaptation services across …
Ipsen’s response to NICE’s decision on Cabometyx® (cabozantinib) for previously treated differentiated thyroid cancer unsuitable for or refractory to radioactive iodine
April 5, 2023 Business Services
SLOUGH, UK, 5th April 2023 – Ipsen is disappointed that the National Institute for Health and Care Excellence (NICE) …
Syncona Appoints Roel Bulthuis as Managing Partner
April 5, 2023 Business Services
05 April 2023 Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life …
First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study
April 5, 2023 Business Services
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …
BenevolentAI announces top-line Phase IIa results for its topical pan-Trk inhibitor BEN-2293 (1%) in mild-to-moderate atopic dermatitis
April 5, 2023 Business Services
London, UK, 5 April 2023: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI) announces top-line results from its Phase IIa, …
Phlo acquires Truepill UK in landmark digital pharmacy consolidation
April 4, 2023 Business Services
Glasgow, UK. Phlo Technologies UK digital pharmacy leaders, have today announced their acquisition of the UK arm of US-based healthcare …
Latest content
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026
